StockData
Lisata Therapeutics, Inc. logo

Lisata Therapeutics, Inc. (LSTA) stock

LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.04−0.05 (-4.59%)

Close on Nov 17, 2026Market cap $9.37MP/E –Yield –

Lisata Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Lisata Therapeutics's profit margin for the twelve months ending Jun 30, 2026 was -14621.0%. For fiscal 2025 it was -9756.5%, against -1998.5% the year before. The highest annual figure on record is -33.4% in fiscal 2010.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-9756.5%−7758.0
FY2024Dec 31, 2024-1998.5%−1905.9
FY2016Dec 31, 2016-92.6%+213.3
FY2014Dec 31, 2014-305.9%−40.1
FY2013Dec 31, 2013-265.7%+109.5
FY2012Dec 31, 2012-375.2%+93.8
FY2011Dec 31, 2011-469.0%−435.6
FY2010Dec 31, 2010-33.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2025Dec 31, 2025-2954.0%–
Q2 FY2025Jun 30, 2025-6655.7%–
Q4 FY2024Dec 31, 2024-461.0%–

More Lisata Therapeutics figures

See a number that looks wrong?